Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Celiac Disease | Research

The financial impact on people with coeliac disease of withdrawing gluten-free food from prescriptions in England: findings from a cross-sectional survey

Authors: Thavapriya Sugavanam, Helen Crocker, Mara Violato, Michele Peters

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

A lifelong gluten-free diet is the only treatment for coeliac disease. The cost and availability of gluten-free substitute food (GFSF) remain challenging. Some local areas in England have stopped gluten-free prescriptions for coeliac disease. The aim of this paper is to present the quantitative findings of the financial impact of prescription withdrawal on people with coeliac disease.

Methods

A cross-sectional survey with adults in England who reported having been diagnosed with coeliac disease by a health professional. The postal survey was distributed by Coeliac UK to their members in 13 prescribing and 13 non-prescribing local areas that were matched for geographical location and level of deprivation. Additionally, an advertisement for the survey was placed on social media. The questionnaire contained items on the availability and use of prescriptions; the weekly amount spent on GFSF; amount of specific GFSF bought; affordability of GFSF; demographics and health-related variables. Data were analysed by descriptive statistics, analysis of variance and regression analysis.

Results

Of the 1697 participants, 809 resided in areas that provided prescriptions and 888 in non-prescribing areas. Participants self-report of their prescription did not always match the local area prescription policy. There was no statistically significant difference between prescribing and non-prescribing areas in how easy or difficult participants found it to obtain GFSF (p = 0.644) and its availability in various locations. Participants in non-prescribing areas purchased most types of GFSF items in statistically significantly higher quantities and thereby spent an additional £11.32/month on GFSF items than participants in prescribing areas (p < 0.001). While taking into account the self-reported prescription status, the amount increased to £14.09/month (p < 0.001). Although affordability to buy GFSF did not differ based on local area prescription policy or self-reported prescription status, it was dependent on equivalised annual income. However, affordability did not influence spending on GFSF. Regression analysis indicated that males and households with additional members with coeliac disease spent more on GFSF.

Conclusions

The study has highlighted that gluten-free prescription withdrawal can have financial implications for people with coeliac disease. Any future changes to the prescription policy of GFSF should consider the impact on the population, especially lower income households.
Appendix
Available only for authorised users
Literature
1.
2.
Ciacci C, Ciclitira P, Hadjivassiliou M, Kaukinen K, Ludvigsson JF, McGough N, Sanders DS, Woodward J, Leonard JN, Swift GL. The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United European Gastroenterol J. 2015;3(2):121–35.CrossRefPubMedPubMedCentral
3.
Al-sunaid FF, Al-homidi MM, Al-qahtani RM, Al-ashwal RA, Mudhish GA, Hanbazaza MA, Al-zaben AS. The influence of a gluten-free diet on health-related quality of life in individuals with celiac disease. BMC Gastroenterol. 2021;21(1):330.CrossRefPubMedPubMedCentral
4.
Enaud R, Tetard C, Dupuis R, Laharie D, Lamireau T, Zerbib F, Rivière P, Shili-Mismoudi S, Poullenot F. Compliance with gluten free diet is associated with better quality of life in celiac disease. Nutrients. 2022;14(6):1210.CrossRefPubMedPubMedCentral
5.
Violato M, Gray A. The impact of diagnosis on health-related quality of life in people with coeliac disease: a UK population-based longitudinal perspective. BMC Gastroenterol. 2019;19(1):68.CrossRefPubMedPubMedCentral
6.
Burger JPW, de Brouwer B, IntHout J, Wahab PJ, Tummers M, Drenth JPH. Systematic review with meta-analysis: dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr. 2017;36(2):399–406.CrossRefPubMed
7.
Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, Green PH, Hadjivassiliou M, Holdoway A, van Heel DA, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210–28.CrossRefPubMed
8.
Muhammad H, Reeves S, Jeanes YM. Identifying and improving adherence to the gluten-free diet in people with coeliac disease. Proc Nutr Soc. 2019;78(3):418–25.CrossRefPubMed
9.
Makharia GK, Singh P, Catassi C, Sanders DS, Leffler D, Ali RAR, Bai JC. The global burden of coeliac disease: opportunities and challenges. Nat Rev Gastroenterol Hepatol. 2022;19(5):313–27.CrossRefPubMed
10.
Shah S, Akbari M, Vanga R, Kelly CP, Hansen J, Theethira T, Tariq S, Dennis M, Leffler DA. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109(9):1304–11.CrossRefPubMedPubMedCentral
11.
12.
Singh J, Whelan K. Limited availability and higher cost of gluten-free foods. J Hum Nutr Diet. 2011;24(5):479–86.CrossRefPubMed
13.
Zarkadas M, Dubois S, MacIsaac K, Cantin I, Rashid M, Roberts KC, La Vieille S, Godefroy S, Pulido OM. Living with coeliac disease and a gluten-free diet: a Canadian perspective. J Hum Nutr Diet. 2013;26(1):10–23.CrossRefPubMed
14.
De Las H-D, Alías-Guerrero ALN, Cendra-Duarte E, Salas-Salvadó J, Vilchez E, Roger E, Hernández-Alonso P, Babio N. Assessment of price and nutritional quality of gluten-free products versus their analogues with gluten through the algorithm of the nutri-score front-of-package labeling system. Food Funct. 2021;12(10):4424–33.CrossRef
15.
Hanci O, Jeanes YM. Are gluten-free food staples accessible to all patients with coeliac disease? Frontline Gastroenterol. 2019;10(3):222–8.CrossRefPubMed
16.
Burden M, Mooney PD, Blanshard RJ, White WL, Cambray-Deakin DR, Sanders DS. Cost and availability of gluten-free food in the UK: in store and online. Postgrad Med J. 2015;91(1081):622–6.CrossRefPubMed
17.
Jegede O, Enns A, Kantounia M, Preun T, Vagianos K, Suh M, Blewett H. Cost, nutritional content and number of gluten-free staple foods available in Winnipeg, Manitoba, Canada. Plant Foods Hum Nutr. 2021;76(2):196–202.CrossRefPubMed
18.
Estévez V, Ayala J, Vespa C, Araya M. The gluten-free basic food basket: a problem of availability, cost and nutritional composition. Eur J Clin Nutr. 2016;70(10):1215–7.CrossRefPubMed
19.
Jamieson JA, Gougeon L. Gluten-free foods in rural maritime provinces: limited availability, high price, and low iron content. Can J Diet Pract Res. 2017;78(4):192–6.CrossRefPubMed
20.
Pinto-Sanchez MI, Verdu EF, Gordillo MC, Bai JC, Birch S, Moayyedi P, Bercik P. Tax-deductible provisions for gluten-free diet in Canada compared with systems for gluten-free diet coverage available in various countries. Can J Gastroenterol Hepatol. 2015;29(2):104–10.CrossRefPubMedPubMedCentral
21.
Coeliac UK. Gluten-free foods: a revised prescribing guide 2011. High Wycombe: Coeliac UK; 2011.
22.
Walker AJ, Curtis HJ, Bacon S, Croker R, Goldacre B. Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study. BMJ Open. 2018;8(3):e021312.CrossRefPubMedPubMedCentral
23.
24.
Linton MJ, Jones T, Owen-Smith A, Payne RA, Coast J, Glynn J, Hollingworth W. Breaking bread: examining the impact of policy changes in access to state-funded provisions of gluten-free foods in England. BMC Med. 2018;16(1):119.CrossRefPubMedPubMedCentral
25.
Muhammad H, Reeves S, Ishaq S, Mayberry J, Jeanes YM. Adherence to a gluten free diet is associated with receiving gluten free foods on prescription and understanding food labelling. Nutrients. 2017;9(7):705.CrossRefPubMedPubMedCentral
26.
Peters M, Crocker H, Jenkinson C, Violato M. Withdrawing gluten-free food from prescriptions in England: a mixed-methods study to examine the impact of policy changes on quality of life. J Hum Nutr Diet. 2020;33(4):453–64.CrossRefPubMed
27.
Crocker H, Lewis T, Violato M, Peters M. The affordability and obtainability of gluten-free foods for adults with coeliac disease following their withdrawal on prescription in England: a qualitative study. J Hum Nutr Diet. 2023;1–10.
28.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRefPubMedPubMedCentral
29.
Crocker H, Jenkinson C, Peters M. Quality of life in coeliac disease: item reduction, scale development and psychometric evaluation of the Coeliac Disease Assessment Questionnaire (CDAQ). Aliment Pharmacol Ther. 2018;48(8):852–62.CrossRefPubMedPubMedCentral
30.
Leffler DA, Dennis M, Edwards George JB, Jamma S, Magge S, Cook EF, Schuppan D, Kelly CP. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7(5):530-536.e531-532.CrossRefPubMed
31.
National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual. In: Process and methods [PMG36]. London: NICE; 2022.
32.
Hernández Alava M, Pudney S, Wailoo A. Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study. Pharmacoeconomics. 2023;41(2):199–207.CrossRefPubMed
33.
34.
Fry L, Madden AM, Fallaize R. An investigation into the nutritional composition and cost of gluten-free versus regular food products in the UK. J Hum Nutr Diet. 2018;31(1):108–20.CrossRefPubMed
35.
36.
37.
Vriesekoop F, Wright E, Swinyard S, Koning WD. Gluten-free products in the UK retail environment. Availability, pricing, consumer opinions in a longitudinal study. Int J Celiac Dis. 2020;8(3):95–103.
38.
Coeliac UK. The gluten free diet: how much does it cost and why does it matter? High Wycombe: Coeliac UK; 2023.
39.
Violato M, Gray A. The economic burden of coeliac disease in the UK: a retrospective population based study. In: Coeliac UK Research Conference 2017. 2017.
40.
King JA, Jeong J, Underwood FE, Quan J, Panaccione N, Windsor JW, Coward S, deBruyn J, Ronksley PE, Shaheen AA, et al. Incidence of celiac disease is increasing over time: a systematic review and meta-analysis. Am J Gastroenterol. 2020;115(4):507–25.CrossRefPubMed
41.
Department for Environment Food and Rural Affairs. National Statistics: Family Food 2020/21. London: Department for Environment Food and Rural Affairs; 2023.
42.
Marmot M, Allen J, Boyce T, Goldblatt P, Morrison J. Health equity in England: the Marmot review 10 years on. London: Institute of Health Equity; 2020.
43.
Department of Health and Social Care. Consultation on the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Amendment) regulations 2018 - gluten free food on NHS prescription in England. London: DHSC; 2018.
44.
45.
Office for National Statistics. Population of England and Wales. Newport: Office for National Statistics; 2022.
46.
Office for National Statistics. Household income. Newport: Office for National Statistics; 2022.
Metadata
Title
The financial impact on people with coeliac disease of withdrawing gluten-free food from prescriptions in England: findings from a cross-sectional survey
Authors
Thavapriya Sugavanam
Helen Crocker
Mara Violato
Michele Peters
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-024-10600-4

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue

Research

Developing an initial set of quality indicators for chiropractic care: a scoping review

Research

A patient activation intervention in primary care for patients with chronic pain on long term opioid therapy: results from a randomized control trial

Study Protocol

Assertive community treatment for high-utilizing alcohol misuse patients: a before-and-after cohort study protocol

Research

“Problems you can live with” versus emergencies: how community members in rural Ethiopia contend with conditions requiring surgery

Research

Reliability and validity of the Patient Experiences Questionnaire for Interdisciplinary Treatment for Substance Dependence – Continuous Electronic Measurement (PEQ-ITSD – CEM)

Research

Associations between outpatient care and later hospital admissions for patients with chronic obstructive pulmonary disease - a registry study from Norway